Transitional care intervention for Alzheimer's patients and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the efficacy of the Connect-Home ADRD intervention, which aims to support patients with Alzheimer's disease and related dementias (ADRD) and their caregivers during transitions from Skilled Nursing Facilities (SNFs) to home or other care settings. It employs a cluster randomized trial design involving 12 SNFs in North Carolina, where half will receive the intervention and half will serve as a control group. The primary goals are to reduce caregiver strain and improve patient neuropsychiatric symptoms through structured support from Dementia Caregiving Specialists.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients:

* Ability to speak English
* Goal of discharge to home, assisted living, or long-term care
* Diagnosis of dementia
* Having a caregiver willing to participate

Caregivers:

* Ability to speak English
* Legally authorized representative (LAR) who also provides support for the person with ADRD

Inclusion criteria for SNFs:

* Location within 120 miles of UNC-Chapel Hill
* Admission of at least 75 SNF patients per year

Exclusion Criteria:

Patients:

* Planned hospital readmission for procedures or treatments within 30 days post enrollment.

Caregivers:

* LAR is a court-appointed guardian.

Where it's running

• University of North Carolina at Chapel Hill
  Chapel Hill, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Mark Toles, PhD, RN — University of North Carolina, Chapel Hill
• Study coordinator: Molly Lynch, MS
• Email: molly_lynch@unc.edu
• Phone: 9198438874

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood biomarker cohort for memory disorders in older adults

  This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.

  Recruiting Yonsei University · Seoul, Seodamun-gu · NCT07880275

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Norms for a Voice-Based Digital Cognitive Test Across Ages

  This study tests a voice-enabled digital cognitive test to establish normal scores for adults aged 18–100.

  Recruiting The Neurology Center of Southern California · Carlsbad, California · NCT07763392

• Lived Experience Narratives in Dementia

  This project tests a digital Online LEND Intervention that shares dementia patients’ and caregivers’ lived experiences to see if it helps wellbeing and connection.

  Recruiting at 2 sites University of Nottingham · Nottingham, England and 1 other locations · NCT07757178

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Far-Infrared Therapy for Alzheimer’s Disease Dementia

  This trial tests whether a far-infrared radiator can help people with Alzheimer's-related dementia who are on stable dementia medications.

  Recruiting National Defense Medical Center, Taiwan · Taipei · NCT07672171

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.